Home›Stock Screener›Glenmark Pharmaceuticals›P/E Ratio

Glenmark Pharmaceuticals P/E Ratio

Current P/E Ratio
37.94
High Valuation
Very High - High growth expectations or significantly overvalued

Glenmark Pharmaceuticals (GLENMARK) P/E ratio is 37.94 (High), EPS (TTM) ₹48.26, current price ₹2447.40 on NSE vs historical average P/E of 22.92 (87.5th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Glenmark Pharmaceuticals share price today.

Current Valuation Metrics

P/E Ratio 37.94
Current Price ₹2447.40
EPS (TTM) ₹48.26
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.92
Historical Range 10.2 - 42.78
Percentile 87.5%

Sector Context

Sector Average 56.89
Sector Median 31.66
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹49.58
Mar 2026 ₹10.68
Jun 2026 ₹17.11

GLENMARK P/E Ratio — Valuation Signal & Historical Context

Glenmark Pharmaceuticals P/E 37.94 vs historical average 22.92, range 10.2–42.78 — signal: Overvalued. Also explore GLENMARK share price charts to track price trends across different timeframes.

  • Stock appears overvalued with PE of 37.94, suggesting caution for new investments
  • Current PE is 65.5% above historical average
  • Trading at discount to sector average PE of 56.89

Glenmark Pharmaceuticals P/E Ratio Historical Trend

GLENMARK annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 37.94 vs historical average 22.92.

GLENMARK Historical P/E Ratio — EPS, Year-End Price & Valuation

Glenmark Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.78 37.74 ₹1614.50 NSE High
2022 16.82 31.22 ₹525.25 NSE Moderate
2021 13.91 36.14 ₹502.60 NSE Low
2020 10.2 33.9 ₹345.70 NSE Low
2019 27.23 25.42 ₹692.15 NSE High
2018 18.39 32.42 ₹596.10 NSE Moderate
2017 29.84 29.62 ₹884.00 NSE High
2016 24.21 38.15 ₹923.75 NSE Moderate

GLENMARK vs Healthcare Peers — P/E Ratio Comparison

Glenmark Pharmaceuticals P/E 37.94 vs Healthcare average 56.89, median 31.66 — range 1.99–747.21.

Sector Average
56.89
Sector Median
31.66
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 1.99 ₹66 Low
Murae Organisor MURAE 2.86 ₹41 Low
Colinz Laboratories COLINZ 3.27 ₹9 Low
Phaarmasia PHRMASI 3.41 ₹59 Low
Sun Pharma Advanced Rese… SPARC 4.03 ₹6,361 Low
Dipna Pharmachem DPL 4.65 ₹12 Low
JFL Life Sciences JFLLIFE 4.95 ₹67 Low
Shelter Pharma SHELTER 5.71 ₹56 Low
GKB Ophthalmics GKB 5.9 ₹33 Low
Kabra Drugs KABRADG 6.29 ₹49 Low